InvestorsHub Logo
Followers 20
Posts 1493
Boards Moderated 0
Alias Born 11/20/2011

Re: jorneyman5 post# 128869

Monday, 03/15/2021 3:13:40 PM

Monday, March 15, 2021 3:13:40 PM

Post# of 136066

Positive revenues and profits have been reported and look at where the stock price is at. I'm saying that the share price wasn't able to even maintain a 2 cent pps but somehow a 50:1 reverse stock split is somehow now going to draw positive attention to the company and attract deep pocket investors



The revenues and profits HAVE boosted the share price. A year ago the price was around .0004. News of mask sales doubled it. News of strong revenues boosted it again to over .0030 for a long while. New sites, and a solid Q3, and getting current boosted it more. It's now 15 times where it was a year ago, and that's all because of increased revenue and profitability and improved prospects for future revenue.

Share price is actually much HIGHER now than it was the last time any revenue reports or changes in guidance were made (about double).

So, yes, absolutely, revenues and profits have helped a lot. The spike to .02 happened a couple months after the last quarterly report or change in revenue guidance, so it had nothing to do with a change in expectations on revenue. It was all about awareness of BRAV increasing, coinciding with an overheating of the entire OTC market.

I don't think anyone's saying that the RS is all that's needed, but it does play a role in raising awareness and palatability by getting through people's stock screens and possibly uplisting.

Still, awareness will only account for 10% to 20% of the long term price. The other 80% to 90% is all about revenues and profits.
The RS is clearly not all that's needed, but that doesn't make it useless either.